{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:06:40Z","timestamp":1777446400588,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Germline mutations in the <jats:italic>CDH1<\/jats:italic>-gene are identified as the cause of 30\u201340% of cases of hereditary diffuse gastric cancer, an autosomal-dominant inherited cancer predisposition syndrome. Given this high risk of developing diffuse gastric cancer, carriers of a pathogenic <jats:italic>CDH1<\/jats:italic> germline mutation are advised to undergo prophylactic gastrectomy. For patients preferring conservative management, endoscopic surveillance is recommended. The detection of diffuse gastric cancer using white light endoscopy, however, remains challenging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients with pathogenic <jats:italic>CDH1<\/jats:italic> mutation underwent (chromo)endoscopic surveillance or endoscopy prior to surgery. Biopsies were taken at suspicious sites identified by chromoendoscopy. In addition, endoscopically normal areas were assessed with mapping biopsies. Detection rates from endoscopic biopsies (mapping vs. targeted) and gastrectomy specimen were then compared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Between 11\/2015 and 12\/2020, ten patients from four families with a known <jats:italic>CDH1<\/jats:italic> germline mutation had a total of <jats:italic>n<\/jats:italic>\u2009=\u200924 endoscopies with <jats:italic>n<\/jats:italic>\u2009=\u2009518 total biopsies being examined. Three patients were diagnosed with GC during the study period. These patients all had suspicious chromoendoscopic lesions (=\u2009detection rate 100%). In two of three patients who had suspicious chromoendoscopic lesions, signet cell carcinoma was also detected in mapping biopsies and multiple additional cancer <jats:italic>foci<\/jats:italic> were identified in the gastrectomy specimen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Chromoendoscopy facilitated detection of gastric carcinoma <jats:italic>foci<\/jats:italic> in <jats:italic>CDH1<\/jats:italic> mutation carriers. Chromoendoscopy identified all patients with gastric cancer, but not all cancer <jats:italic>foci<\/jats:italic> present in these patients. We conclude that for patients opting against prophylactic total gastrectomy, the addition of chromoendoscopy to white light could be used to enhance diagnostic reliability of endoscopic surveillance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12029-022-00831-1","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T10:02:59Z","timestamp":1651485779000},"page":"520-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance"],"prefix":"10.1007","volume":"54","author":[{"given":"Benjamin","family":"Ruf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Roggia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Mattern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falko","family":"Fend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Klag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"G\u00f6tz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"key":"831_CR1","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","DOI":"10.3322\/caac.21492"},{"issue":"2","key":"831_CR2","doi-asserted-by":"publisher","first-page":"E60","DOI":"10.1016\/S1470-2045(14)71016-2","volume":"16","author":"C Oliveira","year":"2015","unstructured":"Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol. 2015;16(2):E60-70.","journal-title":"Lancet Oncol"},{"key":"831_CR3","unstructured":"National Center For Biotechnology Information. Cdh1 On. 2017. Available from: https:\/\/Omim.Org\/Entry\/192090?Search=Cdh1%20&Highlight=Cdh1\u00a0(Cited 18 Aug 2019)"},{"issue":"6674","key":"831_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/32918","volume":"392","author":"P Guilford","year":"1998","unstructured":"Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392(6674):402\u20135.","journal-title":"Nature"},{"issue":"1","key":"831_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","volume":"1","author":"S Hansford","year":"2015","unstructured":"Hansford S, Kaurah P, Li-Chang H, et al. Hereditary diffuse gastric cancer syndrome: Cdh1 mutations and beyond. JAMA Oncol. 2015;1(1):23\u201332.","journal-title":"JAMA Oncol"},{"key":"831_CR6","doi-asserted-by":"crossref","unstructured":"Cho J, Ahn S, Son DS, et al. Bridging genomics and phenomics of gastric carcinoma. Int J Cancer. 2019;145(9):2407\u201317.","DOI":"10.1002\/ijc.32228"},{"key":"831_CR7","doi-asserted-by":"crossref","unstructured":"Roberts ME, Ranola JMO, Marshall ML, et al. Comparison of Cdh1 penetrance estimates in clinically ascertained families vs families ascertained for multiple gastric cancers. JAMA Oncol. 2019.","DOI":"10.1001\/jamaoncol.2019.1208"},{"key":"831_CR8","doi-asserted-by":"crossref","unstructured":"van der Post RS, Vogelaar IP, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline Cdh1 mutation carriers. J Med Genet. 2015;52(6):361\u201374.","DOI":"10.1136\/jmedgenet-2015-103094"},{"key":"831_CR9","doi-asserted-by":"crossref","unstructured":"Fitzgerald RC, Hardwick R, Huntsman D, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47(7):436\u201344.","DOI":"10.1136\/jmg.2009.074237"},{"key":"831_CR10","doi-asserted-by":"crossref","unstructured":"Chen Y, Kingham K, Ford JM, et al. A prospective study of total gastrectomy for Cdh1-positive hereditary diffuse gastric cancer. Ann Surg Oncol. 2011;18(9):2594\u20138.","DOI":"10.1245\/s10434-011-1648-9"},{"key":"831_CR11","doi-asserted-by":"crossref","unstructured":"Mi EZ, Mi EZ, di Pietro M, et al. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to Cdh1 mutation status. Gastrointest Endosc. 2018;87(2):408\u201318.","DOI":"10.1016\/j.gie.2017.06.028"},{"key":"831_CR12","doi-asserted-by":"crossref","unstructured":"Lim YC, di Pietro M, O'donovan M, et al. Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance. Gastrointest Endosc.\u00a02014;80(1):78\u201387.","DOI":"10.1016\/j.gie.2013.11.040"},{"key":"831_CR13","doi-asserted-by":"crossref","unstructured":"Curtin BF, Gamble LA, Schueler SA, et al. Enhanced endoscopic detection of occult gastric cancer in carriers of pathogenic Cdh1 variants. J Gastroenterol. 2020.","DOI":"10.1007\/s00535-020-01749-w"},{"issue":"4","key":"831_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1136\/gut.2004.049171","volume":"54","author":"D Shaw","year":"2005","unstructured":"Shaw D, Blair V, Framp A, et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut. 2005;54(4):461\u20138.","journal-title":"Gut"},{"issue":"12","key":"831_CR15","doi-asserted-by":"publisher","first-page":"E1305","DOI":"10.1055\/s-0042-112582","volume":"4","author":"R Huneburg","year":"2016","unstructured":"Huneburg R, Marwitz T, Van Heteren P, et al. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in Cdh1 mutation positive patients. Endoscopy International Open. 2016;4(12):E1305\u201310.","journal-title":"Endoscopy International Open"},{"key":"831_CR16","doi-asserted-by":"crossref","unstructured":"Kumar S, Katona BW, Long JM, et al. Endoscopic ultrasound has limited utility in diagnosis of gastric cancer in carriers of Cdh1 mutations.\u00a0Clin Gastroenterol Hepatol.\u00a02020;18(2):505\u20138 E1.","DOI":"10.1016\/j.cgh.2019.04.064"},{"key":"831_CR17","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3389\/fphar.2018.01421","volume":"9","author":"W Luo","year":"2018","unstructured":"Luo W, Fedda F, Lynch P, Tan D. Cdh1 gene and hereditary diffuse gastric cancer syndrome: molecular and histological alterations and implications for diagnosis and treatment. Front Pharmacol. 2018;9:1421.","journal-title":"Front Pharmacol"},{"key":"831_CR18","doi-asserted-by":"crossref","unstructured":"Melo S, Figueiredo J, Fernandes MS, et al. Predicting the functional impact Of Cdh1 missense mutations in hereditary diffuse gastric cancer.\u00a0Int J Mol Sci. 2017;18(12).","DOI":"10.3390\/ijms18122687"},{"issue":"4","key":"831_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/jmedgenet-2018-105807","volume":"56","author":"J Figueiredo","year":"2019","unstructured":"Figueiredo J, Melo S, Carneiro P, et al. Clinical spectrum and pleiotropic nature of Cdh1 germline mutations. J Med Genet. 2019;56(4):199\u2013208.","journal-title":"J Med Genet"},{"issue":"6","key":"831_CR20","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/jmedgenet-2018-105361","volume":"56","author":"W Lo","year":"2019","unstructured":"Lo W, Zhu B, Sabesan A, et al. Associations of Cdh1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (Hdgc). J Med Genet. 2019;56(6):370\u20139.","journal-title":"J Med Genet"},{"key":"831_CR21","doi-asserted-by":"crossref","unstructured":"Lewis FR, Mellinger JD, Hayashi A, et al. Prophylactic total gastrectomy for familial gastric cancer. Surgery. 2001;130(4):612\u20137; Discussion 7\u20139.","DOI":"10.1067\/msy.2001.117099"},{"key":"831_CR22","doi-asserted-by":"crossref","unstructured":"Jacobs MF, Dust H, Koeppe E, et al. Outcomes of endoscopic surveillance in individuals with genetic predisposition to hereditary diffuse gastric cancer. Gastroenterology. 2019;157(1):87\u201396.","DOI":"10.1053\/j.gastro.2019.03.047"},{"key":"831_CR23","doi-asserted-by":"crossref","unstructured":"Goetz M, Malek NP, Kiesslich R. Microscopic imaging in endoscopy: endomicroscopy and endocytoscopy.\u00a0Nat Rev Gastroenterol Hepatol.\u00a02014;11(1):11\u20138.","DOI":"10.1038\/nrgastro.2013.134"},{"key":"831_CR24","doi-asserted-by":"crossref","unstructured":"Kumar S, Katona BW, Long JM, et al. Endoscopic ultrasound has limited utility in diagnosis of gastric cancer in carriers of Cdh1 mutations.\u00a0Clin Gastroenterol Hepatol. 2020;18(2):505\u20138.E1.","DOI":"10.1016\/j.cgh.2019.04.064"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-022-00831-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-022-00831-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-022-00831-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T04:38:38Z","timestamp":1692247118000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-022-00831-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s12029-022-00831-1","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"22 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent to be included in the study, or the equivalent, was obtained from all patients. This cohort analysis was approved by the ethics committee of the medical faculty of the University of T\u00fcbingen (project number: 216\/2019BO2).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"All authors gave their consent to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"MG has received speaking honoraria from Pentax, Europe. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}